Physician

Nyan Wai Phyo, MD

According to 2025 Medicare claims, Nyan Phyo, MD (NPI: 1669786042) practices nephrology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is PHYO KIDNEY CARE PA (NPI: 1093220113; TIN: 823286829) and primary practice location at 78503-9998.

Phyo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 340 traditional Medicare patients, billed 2,630 HCPCS/CPT codes, and received $348,531 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,876 prescription claims across 486 beneficiaries totaling $1,438,368 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2022 DME data shows 38 claims. Open Payments data shows 95 records totaling $1,830. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,063 and ending at $348,531. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $23,935 to $1,438,368. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	15	35	$2,063
2017	660	4,607	$335,148
2018	492	2,239	$224,227
2019	756	4,504	$447,479
2020	594	4,271	$427,601
2021	457	3,312	$379,725
2022	364	2,932	$329,318
2023	357	2,883	$359,123
2024	340	2,630	$348,531

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	26	96	$23,935
2016	66	125	$16,886
2017	203	687	$190,497
2018	138	635	$237,711
2019	145	720	$353,364
2020	159	956	$371,988
2021	167	1,030	$423,494
2022	181	1,149	$539,591
2023	364	1,920	$932,241
2024	486	2,876	$1,438,368

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	22	$863
2017	N/R	179	$7,249
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	38	$1,244
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	92	593	$266
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	86	93	$131
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	80	179	$93
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	169	937	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	107	365	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	165	4,972	$422,245
Lupkynis	Voclosporin	13	390	$131,717
Xphozah	Tenapanor Hcl	38	1,373	$128,943
Lokelma	Sodium Zirconium Cyclosilicate	125	4,123	$90,642
Veltassa	Patiromer Calcium Sorbitex	70	2,742	$83,141

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	95	$1,830	Vifor Pharma, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nyan Wai Phyo, MD?

Tedicare shows public-source Medicare data for Nyan Wai Phyo, MD (NPI 1669786042), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nyan Wai Phyo, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nyan Wai Phyo, MD?

Nyan Wai Phyo, MD is linked to PHYO KIDNEY CARE PA (billing NPI 1093220113) in the available physician profile data.

Does Nyan Wai Phyo, MD have Open Payments data?

Nyan Wai Phyo, MD has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.